Li et al. [135] found that treatment with alpinumisoflavone, which shows antioxidant, anti-inflammatory, and anti-cancer properties, significantly decreased RAD51 levels in both in vitro and in vivo CRC models. Here, RAD51 is linked to colorectal carcinoma.